ROR, Inhibitors

ROR Inhibitors Market Expected to Witness Significant Growth Through 2034 Due to the Rising Oncology Research and Pipeline Advancements | DelveInsight

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

en | CA7609751028 | ROR | boerse | 67932953 |